Full View

Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation

C Schmidt, F Wiedmann, N Voigt, XB Zhou, J Heijman… - Circulation, 2015 - Am Heart Assoc
Background—Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical
challenge. Mechanism-based approaches to AF therapy are sought to increase …
被引用次数：208 相关文章

Upregulation of K (2P) 3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation

C Schmidt, F Wiedmann, N Voigt, XB Zhou… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical
challenge. Mechanism-based approaches to AF therapy are sought to increase …

Upregulation of K (2P) 3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation

C Schmidt, F Wiedmann, N Voigt, XB Zhou, J Heijman… - …, 2015 - real.mtak.hu
Background-Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical
challenge. Mechanism-based approaches to AF therapy are sought to increase …

Upregulation of K (2P) 3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.

C Schmidt, F Wiedmann, N Voigt, XB Zhou, J Heijman… - Circulation, 2015 - europepmc.org
Background Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical
challenge. Mechanism-based approaches to AF therapy are sought to increase …
[HTML] sonar.ch

[HTML][HTML] Upregulation of K (2P) 3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.

C Schmidt, F Wiedmann, N Voigt, XB Zhou, J Heijman… - Circulation, 2015 - sonar.ch
Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical challenge.
Mechanism-based approaches to AF therapy are sought to increase effectiveness and to …

Upregulation of K (2P) 3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation

C Schmidt, F Wiedmann, N Voigt, XB Zhou… - …, 2015 - cris.maastrichtuniversity.nl
Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical challenge.
Mechanism-based approaches to AF therapy are sought to increase effectiveness and to …

Upregulation of K 2P 3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation

C Schmidt, F Wiedmann, N Voigt, XB Zhou… - 2015 - publications.goettingen-research …
Background—Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical
challenge. Mechanism-based approaches to AF therapy are sought to increase …

Upregulation of K2P3. 1 K+ current causes action potential shortening in patients with chronic atrial fibrillation

C Schmidt, FT Wiedmann, N Voigt, XB Zhou, S Lang… - 2015 - katalog.ub.uni-heidelberg.de
Background-Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical
challenge. Mechanism-based approaches to AF therapy are sought to increase …
[HTML] unifr.ch

[HTML][HTML] Upregulation of K (2P) 3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.

C Schmidt, F Wiedmann, N Voigt, XB Zhou, J Heijman… - Circulation, 2015 - folia.unifr.ch
Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical challenge.
Mechanism-based approaches to AF therapy are sought to increase effectiveness and to …

Upregulation of K 2P 3.1 K + Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation

C Schmidt, F Wiedmann, N Voigt, XB Zhou, J Heijman… - Circulation, 2015 - cir.nii.ac.jp
Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential
Shortening in Patients With Chronic Atrial Fibrillation | CiNii Research CiNii 国立情報学研究所 …